1 - 25 of 131 results for author:"Cunningham J.M." in Literature citations
Results Customize
› Repeat search in UniProtKB (33)
| Disruption of growth factor receptor-binding protein 10 in the pancreas enhances beta-cell proliferation and protects mice from streptozotocin-induced beta-cell apoptosis. Zhang J., Zhang N., Liu M., Li X., Zhou L., Huang W., Xu Z., Liu J., Musi N., DeFronzo R.A. et al. Diabetes 61:3189-3198(2012) · Mapped (3) |
| A two-stage evaluation of genetic variation in immune and inflammation genes with risk of non-Hodgkin lymphoma identifies new susceptibility locus in 6p21.3 region. Cerhan J.R., Fredericksen Z.S., Novak A.J., Ansell S.M., Kay N.E., Liebow M., Dogan A., Cunningham J.M., Wang A.H., Witzig T.E. et al. Cancer Epidemiol. Biomarkers Prev. 21:1799-1806(2012) · Mapped (11) |
| p19Arf represses platelet-derived growth factor receptor beta by transcriptional and posttranscriptional mechanisms. Widau R.C., Zheng Y., Sung C.Y., Zelivianskaia A., Roach L.E., Bachmeyer K.M., Abramova T., Desgardin A., Rosner A., Cunningham J.M. et al. Mol. Cell. Biol. 32:4270-4282(2012) · Mapped (24) |
| Ovarian cancer risk associated with inherited inflammation-related variants. Ovarian Cancer Association Consortium Cancer Res. 72:1064-1069(2012) · Mapped (8) |
| Association of TNFSF8 polymorphisms with peripheral neutrophil count. Arruda-Olson A.M., Roger V.L., Chai H.S., de Andrade M., Fridley B.L., Cunningham J.M., Gabriel S.E., Bielinski S.J. Mayo Clin. Proc. 86:1075-1081(2011) · Mapped (2) |
| Large kindred evaluation of mitofusin 2 novel mutation, extremes of neurologic presentations, and preserved nerve mitochondria. Klein C.J., Kimmel G.W., Pittock S.J., Engelstad J.E., Cunningham J.M., Wu Y., Dyck P.J. Arch. Neurol. 68:1295-1302(2011) · Mapped (5) |
| Do interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility? Biernacka J.M., Armasu S.M., Cunningham J.M., Ahlskog J.E., Chung S.J., Maraganore D.M. Parkinsonism Relat. Disord. 17:730-736(2011) · Mapped (17) |
| The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy. Sundaresan N.R., Pillai V.B., Wolfgeher D., Samant S., Vasudevan P., Parekh V., Raghuraman H., Cunningham J.M., Gupta M., Gupta M.P. Sci. Signal. 4:RA46-RA46(2011) · UniProtKB (2) · Mapped (30) |
| Mutations in DNMT1 cause hereditary sensory neuropathy with dementia and hearing loss. Klein C.J., Botuyan M.V., Wu Y., Ward C.J., Nicholson G.A., Hammans S., Hojo K., Yamanishi H., Karpf A.R., Wallace D.C. et al. |
| Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk. Ovarian Cancer Association Consortium Mol. Carcinog. 50:397-402(2011) · Mapped (12) |
| Inflammation-related gene variants as risk factors for pancreatic cancer. Reid-Lombardo K.M., Fridley B.L., Bamlet W.R., Cunningham J.M., Sarr M.G., Petersen G.M. Cancer Epidemiol. Biomarkers Prev. 20:1251-1254(2011) · Mapped (5) |
| Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk. Permuth-Wey J., Chen Y.A., Tsai Y.Y., Chen Z., Qu X., Lancaster J.M., Stockwell H., Dagne G., Iversen E., Risch H. et al. Cancer Epidemiol. Biomarkers Prev. 20:1131-1145(2011) · Mapped (29) |
| The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. kConFab Investigators and the Consortium of Investigators of Modifiers of BRCA1/2 Clin. Cancer Res. 17:3742-3750(2011) · Mapped (7) |
| CYP2C19 variation and citalopram response. Mrazek D.A., Biernacka J.M., O'Kane D.J., Black J.L., Cunningham J.M., Drews M.S., Snyder K.A., Stevens S.R., Rush A.J., Weinshilboum R.M. Pharmacogenet. Genomics 21:1-9(2011) · Mapped (3) |
| Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Slager S.L., Rabe K.G., Achenbach S.J., Vachon C.M., Goldin L.R., Strom S.S., Lanasa M.C., Spector L.G., Rassenti L.Z., Leis J.F. et al. Blood 117:1911-1916(2011) · Mapped (2) |
| Common variants at 19p13 are associated with susceptibility to ovarian cancer. Ovarian Cancer Association Consortium Nat. Genet. 42:880-884(2010) · Mapped (5) |
| A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Wellcome Trust Case-Control Consortium Nat. Genet. 42:874-879(2010) · Mapped (34) |
| Endothelial nitric oxide synthase gene variation associated with chronic kidney disease after liver transplant. Bambha K., Kim W.R., Rosen C.B., Pedersen R.A., Rys C., Kolbert C.P., Cunningham J.M., Therneau T.M. Mayo Clin. Proc. 85:814-820(2010) · Mapped (7) |
| Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. Ovarian Cancer Association Consortium Fertil. Steril. 95:40-45(2011) · Mapped (10) |
| Regional neural tube closure defined by the Grainy head-like transcription factors. Rifat Y., Parekh V., Wilanowski T., Hislop N.R., Auden A., Ting S.B., Cunningham J.M., Jane S.M. Dev. Biol. 345:237-245(2010) · Mapped (14) |
| Epidermal wound repair is regulated by the planar cell polarity signaling pathway. Caddy J., Wilanowski T., Darido C., Dworkin S., Ting S.B., Zhao Q., Rank G., Auden A., Srivastava S., Papenfuss T.A. et al. Dev. Cell 19:138-147(2010) · Mapped (22) |
| Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". Ovarian Cancer Association Consortium PLoS Genet. 6:e1001016-e1001016(2010) · Mapped (594) |
| Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Ovarian Cancer Association Consortium Cancer Epidemiol. Biomarkers Prev. 19:1822-1830(2010) · Mapped (18) |
| Genetic variation in glutathione metabolism and DNA repair genes predicts survival of small-cell lung cancer patients. Sun Z., Chen J., Aakre J., Marks R.S., Garces Y.Y., Jiang R., Idowu O., Cunningham J.M., Liu Y., Pankratz V.S. et al. Ann. Oncol. 21:2011-2016(2010) · Mapped (12) |
| Genetic susceptibility variants for chronic lymphocytic leukemia. Slager S.L., Goldin L.R., Strom S.S., Lanasa M.C., Spector L.G., Rassenti L., Leis J.F., Camp N.J., Kay N.E., Vachon C.M. et al. Cancer Epidemiol. Biomarkers Prev. 19:1098-1102(2010) · Mapped (39) |